Biodyne Co., Ltd. (KOSDAQ:314930)
South Korea · Delayed Price · Currency is KRW 6,910.00
+190.00 (2.83%)
At close: Oct 1, 2026
Biodyne Market Cap
Biodyne has a market cap or net worth of 203.68 billion as of October 1, 2026. Its market cap has decreased by -49.98% in one year.
Market Cap
203.68B
Enterprise Value
188.94B
Revenue
5.77B
Ranking
n/a
PE Ratio
168.99
Stock Price
6,910.00
ChartMarket Cap Chart
Since March 17, 2021, Biodyne's market cap has decreased from 252.12B to 203.68B, a decrease of -19.21%. That is a compound annual growth rate of -3.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 203.68B | -49.31% |
| Dec 30, 2025 | 401.82B | -16.15% |
| Dec 30, 2024 | 479.20B | 19.24% |
| Dec 28, 2023 | 401.88B | 185.76% |
| Dec 29, 2022 | 140.63B | -31.74% |
| Dec 30, 2021 | 206.02B | -18.28% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curiox Biosystems | 1.02T |
| Livsmed | 766.38B |
| BIOBIJOU | 169.96B |
| M.I.TECH Co.,Ltd | 151.15B |
| Synergy Innovation | 140.00B |
| Celemics | 114.95B |
| RecensMedical | 96.80B |
| Corentec | 63.48B |